glp 1 drugs cancer GLP-1 Receptor Agonists: Benefits and Risks in Colorectal Research Reveals Potential Risks of

Bhattacharyya, S., Saha, S., Giri, K., Lanza, I

Suitability depends on individual medical circumstances and should be assessed by a qualified healthcare professional

Selman, C., Partridge, L

No significant differences in plasma levels were seen in the different dosage groups despite a reduction of the total daily dose by up to two thirds (from 1.5g twice daily to 1g once daily)

Clin Cancer Res 18(14):3982-91, 2012

When you access our Services via a mobile device, Publix or its third-party service providers may collect various information, including the type of mobile device you use, the temporary or persistent device identifier associated with your device, the IP address of your mobile device, the device's operating system, the browser you use to access the Services, information about how you use the Services, and your device's location as described below